VIKTOR IS ONLY AVAILABLE TO ACTIVE IASLC MEMBERS
Access to VIKTOR, the IASLC’s bioinformatics platform for thoracic cancer research, is available exclusively to active IASLC members.
Join the IASLC today to explore centralized data on preclinical models that accelerate discovery and advance treatment.
About VIKTOR
VIKTOR currently integrates multiple trusted data sources, including Cellosaurus, NeXtProt, PharmacoDB, and Human Protein Atlas (HPA), to provide researchers with centralized access to published thoracic cancer cell line information. The platform's interactive web interface enables researchers to efficiently address critical challenges in thoracic oncology, including drug resistance mechanisms, targeted therapy development, and combination treatment strategies. In future releases, VIKTOR will introduce AI-powered semantic search capabilities to further streamline research workflows and will incorporate unpublished cell lines from IASLC member laboratories, along with organoid, patient-derived xenograft (PDX), and genetically engineered mouse model (GEMM) data.
As a catalyst for the IASLC thoracic oncology community's research priorities, VIKTOR supports individual researchers in their mission to advance patient care through scientific discovery.
IASLC's Basic & Translational Science Committee
The VIKTOR resource is a project of the IASLC's Basic & Translational Science Committee. Through its collective expertise and collaborative efforts, the Basic and Translational Science Committee at the IASLC strives to accelerate scientific discoveries, improve patient outcomes, and ultimately contribute to the global eradication of thoracic malignancies.